(2013) Summary of Recommendation Statements. Kidney International Supplements 3:5–14. https://doi.org/10.1038/kisup.2012.77

Bikbov B, Purcell CA, Levey AS et al (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 395:709–733. https://doi.org/10.1016/S0140-6736(20)30045-3

Article  Google Scholar 

Rinella ME, Sookoian S (2024) From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease. J Lipid Res 65:100485. https://doi.org/10.1016/j.jlr.2023.100485

Article  CAS  PubMed  Google Scholar 

Ratziu V, Boursier J, AFEF Group for the Study of Liver Fibrosis (2024) (2024) Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD. J Hepatol 80:e51–e52. https://doi.org/10.1016/j.jhep.2023.07.017

Article  PubMed  Google Scholar 

Song SJ, Lai JC-T, Wong GL-H et al (2024) Can we use old NAFLD data under the new MASLD definition? J Hepatol 80:e54–e56. https://doi.org/10.1016/j.jhep.2023.07.021

Article  PubMed  Google Scholar 

Younossi ZM, Golabi P, Paik JM et al (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77:1335–1347. https://doi.org/10.1097/HEP.0000000000000004

Article  PubMed  Google Scholar 

Jaacks LM, Vandevijvere S, Pan A et al (2019) The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol 7:231–240. https://doi.org/10.1016/S2213-8587(19)30026-9

Article  PubMed  PubMed Central  Google Scholar 

Saeedi P, Petersohn I, Salpea P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https://doi.org/10.1016/j.diabres.2019.107843

Article  PubMed  Google Scholar 

Pirillo A, Casula M, Olmastroni E et al (2021) Global epidemiology of dyslipidaemias. Nat Rev Cardiol 18:689–700. https://doi.org/10.1038/s41569-021-00541-4

Article  CAS  PubMed  Google Scholar 

Bilson J, Mantovani A, Byrne CD, Targher G (2024) Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metab 50:101506. https://doi.org/10.1016/j.diabet.2023.101506

Article  PubMed  Google Scholar 

Musso G, Cassader M, Cohney S et al (2015) Emerging liver-kidney interactions in nonalcoholic fatty liver disease. Trends Mol Med 21:645–662. https://doi.org/10.1016/j.molmed.2015.08.005

Article  CAS  PubMed  Google Scholar 

Marcuccilli M, Chonchol M (2016) NAFLD and chronic kidney disease. Int J Mol Sci 17:562. https://doi.org/10.3390/ijms17040562

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsushita K, Ballew SH, Wang AY-M et al (2022) Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol 18:696–707. https://doi.org/10.1038/s41581-022-00616-6

Article  PubMed  Google Scholar 

Bilancio G, Celano M, Cozza V et al (2017) Early prediction of cardiovascular disease in kidney transplant recipients. Transpl Proc 49:2092–2098. https://doi.org/10.1016/j.transproceed.2017.09.005

Article  CAS  Google Scholar 

Coyle M, Flaherty G, Jennings C (2021) A critical review of chronic kidney disease as a risk factor for coronary artery disease. Int J Cardiol Heart Vasc 35:100822. https://doi.org/10.1016/j.ijcha.2021.100822

Article  PubMed  PubMed Central  Google Scholar 

Roberts MA, Hare DL, Ratnaike S, Ierino FL (2006) Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 48:341–360. https://doi.org/10.1053/j.ajkd.2006.06.005

Article  CAS  PubMed  Google Scholar 

Jankowski J, Floege J, Fliser D et al (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143:1157–1172. https://doi.org/10.1161/CIRCULATIONAHA.120.050686

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kasiske BL, Zeier MG, Chapman JR et al (2010) KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 77:299–311. https://doi.org/10.1038/ki.2009.377

Article  PubMed  Google Scholar 

American Diabetes Association Professional Practice Committee (2023) 2. Diagnosis and classification of diabetes: standards of care in diabetes—2024. Diabetes Care 47:S20–S42. https://doi.org/10.2337/dc24-S002

Article  Google Scholar 

Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2:231. https://doi.org/10.1242/dmm.001180

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwenzer NF, Springer F, Schraml C et al (2009) Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51:433–445. https://doi.org/10.1016/j.jhep.2009.05.023

Article  PubMed  Google Scholar 

Tacke F, Horn P, Wai-Sun Wong V et al (2024) EASL–EASD–EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 81:492–542. https://doi.org/10.1016/j.jhep.2024.04.031

Article  CAS  Google Scholar 

Fariña-Hernández A, González-Rinne A, Hernández-Bustabad A et al (2024) Metabolic syndrome, nonalcoholic fatty liver disease, and graft inflammation: an unaddressed pathogenic link after kidney transplantation. Nephron. https://doi.org/10.1159/000543276

Article  PubMed  Google Scholar 

Lin I-H, Yu Y-P, Duong TV et al (2024) Effect of obesity and metabolic health status on metabolic-associated steatotic liver disease among renal transplant recipients using hepatic steatosis index. Nutrients 16:3344. https://doi.org/10.3390/nu16193344

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202–209. https://doi.org/10.1016/j.jhep.2020.03.039

Article  PubMed  Google Scholar 

Marc L, Mihaescu A, Lupusoru R et al (2021) Liver steatosis: better predictor of CKD in MAFLD than liver fibrosis as determined by transient elastography with controlled attenuation parameter. Front Med (Lausanne) 8:788881. https://doi.org/10.3389/fmed.2021.788881

Article  PubMed  Google Scholar 

Bril F, Cusi K (2016) Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus. Endocrinol Metab Clin North Am 45:765–781. https://doi.org/10.1016/j.ecl.2016.06.005

Article  PubMed  Google Scholar 

Chinnadurai R, Ritchie J, Green D, Kalra PA (2019) Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease. Nephrol Dial Transplant 34:449–457. https://doi.org/10.1093/ndt/gfx381

Article  CAS  PubMed  Google Scholar